Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-30 Shefferman Jesse CEO and President Gift −14,000 707,832
2026-06-30 Shefferman Jesse CEO and President Gift −7,000 700,832
2026-06-30 Shefferman Jesse CEO and President Gift −4,000 696,832
2026-06-30 Shefferman Jesse CEO and President Gift −5,000 691,832
2026-06-29 Shefferman Jesse CEO and President Option exercise +215,687 $1.91 $412K 937,519
2026-06-29 Shefferman Jesse CEO and President Sale −215,687 $4.09 $882K 721,832
2026-06-29 Shefferman Jesse CEO and President Option exercise · Stock Option (Right to Buy) −215,687 141,313
2026-06-15 Levy Richard S Director Grant or award · Stock Option (Right to Buy) +31,000 31,000
2026-06-15 Solomon Michael Edward Director Grant or award · Stock Option (Right to Buy) +31,000 31,000
2026-06-15 Smith Cynthia Director Grant or award · Stock Option (Right to Buy) +31,000 31,000
2026-06-15 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +31,000 31,000
2026-06-15 Huang Jane Director Grant or award · Stock Option (Right to Buy) +31,000 31,000
2026-06-15 GARCEAU ROGER Director Grant or award · Stock Option (Right to Buy) +31,000 31,000
2026-06-15 Flannelly Barry P Director Grant or award · Stock Option (Right to Buy) +31,000 31,000
2026-06-15 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +31,000 31,000
2026-06-02 CONKLING WILLIAM Chief Commercial Officer Shares withheld for taxes −6,008 $4.34 $26K 69,992
2026-04-08 Zummo Jacqueline Chief R&D Officer Sale −1,134 $5.40 $6K 94,827
2026-04-01 Zummo Jacqueline Chief R&D Officer Sale −22,598 $5.26 $119K 95,961
2026-01-26 Shefferman Jesse CEO and President Shares withheld for taxes −8,732 $6.67 $58K 1,021,832
2026-01-26 Zummo Jacqueline Chf Scientific Operations Off Shares withheld for taxes −3,724 $6.67 $25K 118,559

Page 1 of 17 · 335 trades